Trial Profile
A study of the effect of conversion to enteric-coated mycophenolate sodium on quality of life in patients with gastrointestinal symptoms related to mycophenolate mofetil therapy after renal transplantation
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 27 Jul 2011
Price :
$35
*
At a glance
- Drugs Mycophenolate sodium (Primary) ; Mycophenolate mofetil
- Indications Renal transplant rejection
- Focus Adverse reactions
- Sponsors Novartis
- 27 Jul 2011 New trial record
- 14 Jul 2011 Results published in the Transplantation.